Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
Yanxia Zhao(National Center for Women and Children’s Health, China CDC), Jiuling Wu(National Center for Women and Children’s Health, China CDC), Bo Song(National Center for Women and Children’s Health, China CDC), Heling Bao(Chinese Academy of Medical Sciences & Peking Union Medical College), Lınhong Wang(Chinese Center For Disease Control and Prevention), Jiangli Di(Hubei University of Chinese Medicine), Haijun Wang(Hebei Medical University), Wang Shi(Peking University), Yanqiu Gao(Peking University), Wenhui Ren(National Center for Women and Children’s Health, China CDC), Lan Ma(National Center for Women and Children’s Health, China CDC)
Cited by 49
Related Papers
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
|The Lancet Respiratory Medicine|2018|490
Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China
|Gastroenterology|2023|213
Breast Cancer Screening Rates Among Women Aged 20 Years and Above — China, 2015
|China CDC Weekly|2021|121